Medfield Diagnostics and Chalmers University have developed “Strokefinder,” a microwave helmet that quickly determines whether a person has had a stroke, enabling early and appropriate treatment. It has been tested on 45 patients.
The helmet uses microwave typography to determine whether a stroke is caused by a clot or bleeding. Strokes caused by clots require a drug to dissolve the clot within 4.5 hours. Less than 10% of patients diagnosed by CT or MRI get anti-clotting drugs on time, as too much time often elapses between a patient’s hospital arrival and a diagnostic scan. Strokes caused by bleeding require different treatment.
An early prototype involved a modified bike helmet and was able to differentiate between the two types of stroke accurately some of the time. The team has since refined the device, building a custom helmet that better adapts to different skulls. The plan is to carry out a large scale study in order to improve the predictive power of the algorithms.
Case Western‘s Michael Bruckman and colleagues have developed a multifunctional nanoparticle that pinpoints blood vessel plaques caused by atherosclerosis using MRI. The goal is to create a non-invasive method of identifying heart attack and stroke causing plaques vulnerable to rupture, in time for treatment.
Currently doctors can only identify narrowing blood vessels caused by plaque accumulation via incision and the insertion of a catheter inside a blood vessel in the arm, groin or neck. The catheter emits a dye that enables X-rays to show the narrowing.
The researchers found that a nanoparticle built from a rod-shaped virus, commonly found on tobacco, locates and illuminates plaque in arteries more effectively, with a fraction of the dye. The tailored nanoparticles target plaque biomarkers, opening the possibility that particles can be programmed to identify vulnerable plaques from stable. Untargeted dyes alone cannot accomplish this.
Sun Yat-sen University researchers claim that Kinect based virtual reality training could promote the recovery of upper limb motor function in subacute stroke patients, and brain reorganization by Kinect based training may be linked to the contralateral sensorimotor cortex. They have completed a study in which they located the target brain region for Kinect based intervention and preliminarily explored the mechanism of the system for physical rehabilitation of upper limb dysfunction.
Professor Vivek Prabhakaran at the University of Wisconsin is developing a device that combines a brain-computer interface with electrical stimulation of damaged muscles to help stroke patients relearn how to move limbs. Eight patients who had lost movement in one hand have been through six weeks of therapy with the device. They reported improvements in their ability to complete daily tasks.
Patients wear a cap of electrodes that picks up brain signals. Those signals are decoded by a computer. The computer sends tiny jolts of electricity through wires to sticky pads placed on the muscles of a patient’s paralyzed arm. The jolts act like nerve impulses, telling the muscles to move. A video game prompts patients to try to hit a target by moving a ball with their affected arm. Patients practice with the game for two hours, every other day.
Researchers scanned the patients’ brains before, during and a month after they finished 15 sessions with the device. The more patients practiced, the more they were able to train their brains.
Three projects have been awarded funding by the National Institutes of Health. All involve robots that cooperate with people and adapt to changing environments to improve human capabilities and enhance medical procedures.
- A co-robotic navigation device for the blind: Cang Ye at University of Arkansas is incorporating 3D imaging sensor technology into the white cane. This enables it to detect and relay to the user critical information about the environment, like when there’s a potential obstacle in the way. In related research, Professor Amnon Shashua at The Hebrew University in Jerusalem, through his company OrCam, uses Artificial Vision to compensate for lost visual abilities, and Professor Amir Amedi at the Hebrew University of Jerusalem is also developing cutting edge technology to help the vision impaired. His projects include reading in the blind, sensory substitution devices, multisensory perception, topographic brain, and seeing with music and sound.
- MRI-guided co-robotic catheter: During traditional catheter ablation for the treatment of atrial fibrillation, one of the most common arrhythmias, a catheter with an electrode on its tip is threaded through a vein in a patient’s groin up to the heart. Doctors destroy tissue at certain points on the heart in order to prevent the occurrence of irregular heart activity. The constant movement of the heart and blood can make that process difficult. Researchers at Case Western Reserve University are developing a catheter that uses robotic planning strategies to compensate for those movements to increase accuracy of procedures in conjunction with MRI.
- Platform for exploration of robotic ankle exoskeleton control: Researchers at North Carolina State and Carnegie Mellon are developing a method to compare different wearable devices to assist people recovering from stroke.
Tel Aviv University and Assaf Harofeh Medical Center researchers are treating stroke patients with hyperbaric oxygen therapy (HBOT), high-pressure chambers where oxygen-rich air increases oxygen levels in the body by a factor of ten. Their goal is to reinvigorate dormant neurons and improve patients’ motor function, memory and other abilities that current therapies do not address.
The researchers are studying the potential benefits of HBOT for traumatic brain injury, and as an anti-aging therapy, applicable to Alzheimer’s and vascular dementia patients.
A small, external sensor developed at the University of Pittsburgh records how a person swallows and could result in more efficient and less invasive testing for stroke patients.
Dysphagia can have dire consequences like malnutrition, dehydration, pneumonia, and even death. Current evaluation and monitoring methods are often cumbersome and not as effective as they need to be.